Authors:
Vergis, EN
Hayden, MK
Chow, JW
Snydman, DR
Zervos, MJ
Linden, PK
Wagener, MM
Schmitt, B
Muder, RR
Citation: En. Vergis et al., Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia - A prospective multicenter study, ANN INT MED, 135(7), 2001, pp. 484-492
Authors:
Brooks, A
Ekleberry, A
McMahon, J
Begle, R
Johnson, M
Rizzo, J
Zervos, MJ
Citation: A. Brooks et al., Evaluation of clinical practice guidelines on outcome of infection in medical intensive care unit patients, INF DIS C P, 9(8), 2000, pp. 339-348
Authors:
Kak, V
You, I
Zervos, MJ
Kariyama, R
Kumon, H
Chow, JW
Citation: V. Kak et al., In-vitro synergistic activity of the combination of ampicillin and arbekacin against vancomycin-and high-level gentamicin-resistant Enterococcus faecium with the aph(2 '')-Id gene, DIAG MICR I, 37(4), 2000, pp. 297-299
Authors:
You, I
Kariyama, R
Zervos, MJ
Kumon, H
Chow, JW
Citation: I. You et al., In-vitro activity of arbekacin alone and in combination with vancomycin against gentamicin- and methicillin-resistant Staphylococcus aureus, DIAG MICR I, 36(1), 2000, pp. 37-41
Authors:
Donabedian, S
Hershberger, E
Thal, LA
Chow, JW
Clewell, DB
Robinson-Dunn, B
Zervos, MJ
Citation: S. Donabedian et al., PCR fragment length polymorphism analysis of vancomycin-resistant Enterococcus faecium, J CLIN MICR, 38(8), 2000, pp. 2885-2888
Citation: Jw. Snyder et al., Clinical comparison of nonvented aerobic BacT/Alert blood culture bottle and standard aerobic bottle for detection of microorganisms in blood, J CLIN MICR, 38(10), 2000, pp. 3864-3866
Authors:
Kak, V
Donabedian, SM
Zervos, MJ
Kariyama, R
Kumon, H
Chow, JW
Citation: V. Kak et al., Efficacy of ampicillin plus arbekacin in experimental rabbit endocarditis caused by an Enterococcus faecalis strain with high-level gentamicin resistance, ANTIM AG CH, 44(9), 2000, pp. 2545-2546
Authors:
Hershberger, E
Coyle, EA
Kaatz, GW
Zervos, MJ
Rybak, MJ
Citation: E. Hershberger et al., Comparison of a rabbit model of bacterial endocarditis and an in vitro infection model with simulated endocardial vegetations, ANTIM AG CH, 44(7), 2000, pp. 1921-1924
Authors:
Kao, SJ
You, L
Clewell, DB
Donabedian, SM
Zervos, MJ
Petrin, J
Shaw, KJ
Chow, JW
Citation: Sj. Kao et al., Detection of the high-level aminoglycoside resistance gene aph(2 '')-Ib inEnterococcus faecium, ANTIM AG CH, 44(10), 2000, pp. 2876-2879
Authors:
Brooks, A
Ekleberry, A
McMahon, J
Begle, R
Johnson, M
Rizzo, J
Zervos, MJ
Citation: A. Brooks et al., Evaluation of clinical practice guidelines on outcome of infection in medical intensive care unit patients, INF DIS C P, 8(2), 1999, pp. 97-106
Authors:
Silverman, J
Vazquez, JA
Sobel, JD
Zervos, MJ
Citation: J. Silverman et al., Comparative in vitro activity of antiseptics and disinfectants versus clinical isolates of Candida species, INFECT CONT, 20(10), 1999, pp. 676-684
Authors:
Price, J
Ekleberry, A
Grover, A
Melendy, S
Baddam, K
McMahon, J
Villalba, M
Johnson, M
Zervos, MJ
Citation: J. Price et al., Evaluation of clinical practice guidelines on outcome of infection in patients in the surgical intensive care unit, CRIT CARE M, 27(10), 1999, pp. 2118-2124
Citation: Mj. Zervos, Cefepime versus ceftriaxone for empiric treatment of hospitalized patientswith community-acquired pneumonia - Reply, ANTIM AG CH, 43(2), 1999, pp. 436-437
Authors:
Kariyama, R
Kumon, H
Chow, L
Zervos, MJ
Takata, T
Tabata, M
Chow, JW
Citation: R. Kariyama et al., In-vitro activity of the combination of ampicillin and arbekacin against high-level gentamicin-resistant enterococci, J ANTIMICRO, 42(6), 1998, pp. 836-838